Events
Engine Advocacy | Lunch Panel: Why Patent Quality Matters Across Industries
As we launch Patent Quality Week 2025, join Engine for lunch catered by Bullfrog Bagels and a panel discussion featuring startup founders and patent experts on Thursday, June 26 at 12 PM. RSVP to hear why patent quality matters across industries in 2237 Rayburn House Office Building.
Partner Panel | Seed Patents & Power: How Intellectual Property Law Shapes Our Food System
How do patents on seeds affect what farmers and researchers can grow--and what we all eat? Join leading experts from academia and the seed industry to explore how U.S. intellectual property laws influence seed diversity, prices, and innovation. Hosted by the Public Interest Patent Law Institute.
Engine Advocacy | San Diego In-District Panel: Startups & Patent Quality
As part of Patent Quality Week and Startup Summer 2025, join Engine for hors d'oeuvres and a panel discussion featuring startup founders and patent experts on Monday, June 30 at 4 PM PT. RSVP to hear why high-quality patents are essential to the innovation ecosystem and how low-quality patents pose challenges to startups and small businesses at Hera Hub Mission Valley.
Partner Panel | Unlocking Innovation: The Fight Against SEP Abuse
So much of our modern technology uses standards – whether it’s scrolling on your phone, using telehealth services, taking your new car for a spin, and beyond, your day-to-day life revolves around hundreds of technical standards. Standard essential patent (SEP) holders volunteer to license them on fair, reasonable and non-discriminatory (FRAND) terms. But bad actors often use the legal system to hold SEPs hostage, resulting in costly litigation that stifles innovation. Hosted by Save Our Standards.
Resources
PQW2025
Tackling High Drug Prices Requires Patent Reforms, Too
President Donald J. Trump just released his second executive order (EO) addressing high prescription drug prices. This is perhaps a welcome announcement for those who have to pay for prescription drugs on a regular basis. U.S. drug prices remain nearly three times higher than in other countries leaving many Americans struggling to afford their prescribed medications.
The PERA and PREVAIL Acts Would Make Bad Patents Easier to Get—and Harder to Fight
Two dangerous bills have been reintroduced in Congress that would reverse over a decade of progress in fighting patent trolls and making the patent system more balanced. The Patent Eligibility Restoration Act (PERA) and the PREVAIL Act would each cause significant harm on their own.
Sacrificing patent quality for the sake of “efficiency”
The Trump administration’s push for “efficiency” is undercutting key programs and tools that maintain balanced intellectual property frameworks that protect startups against low-quality patents and meritless, but expensive and time consuming, litigation.
Joint letter urging repeal of the Fintiv rule
This joint letter urges senior U.S. officials to repeal the Fintiv rule and restore fair access to inter partes review while warning that the current policy endangers American innovation by enabling the enforcement of invalid patents.